Missing | In analysis, | Univariate analysis | p-value | Multivariate analysis | p-value | |
---|---|---|---|---|---|---|
data, n | n | HR (95% CI) | HR (95% CI) | |||
Age: | 48 | |||||
< 65 years | 292 | ref. | ||||
≥ 65 years | 244 | 1.039 (0.846–1.276) | 0.718 | |||
Sex: | 46 | |||||
Male | 246 | 1.036 (0.844–1.273) | 0.739 | |||
Female | 292 | ref. | ||||
Neoadjuvant chemo: | 166 | |||||
Yes | 125 | 1.323 (1.031–1.699) | 0.028 | 1.319 (1.019–1.708) | 0.036 | |
No | 293 | ref. | ||||
Any complication: | 51 | |||||
Yes | 305 | 1.081 (0.877–1.333) | 0.464 | |||
No | 228 | ref. | ||||
Severe complication: | 34 | |||||
Yes | 68 | 1.037 (0.765–1.406) | 0.814 | |||
No complication | 228 | ref. | ||||
Not in analysis (C-D 1-3a) | 254 | |||||
Duration of surgery: | 64 | |||||
< 480 min | 271 | ref. | ||||
≥ 480 min | 249 | 1.117 (0.910–1.370) | 0.291 | |||
Postop leukopenia: | 44 | |||||
Yes | 51 | 0.962 (0.676–1.369) | 0.83 | 0.890 (0.586–1.351) | 0.585 | |
No | 489 | ref. | ||||
Severe leukopenia: | 43 | |||||
Yes | 30 | 0.953 (0.670–1.356) | 0.789 | |||
No | 489 | ref. | ||||
Not in analysis (mild leukopenia) | 22 | |||||
PCI-score: | 48 | |||||
0–8 | 265 | ref. | ref. | |||
9–15 | 157 | 1.664 (1.310–2.115) | < 0.001 | 1.452 (1.096–1.922) | 0.09 | |
> 15 | 114 | 1.609 (1.242–2.084) | < 0.001 | 1.497 (1.093–2.050) | 0.012 | |
pN-stage: | 68 | |||||
N0 | 106 | ref. | ref. | |||
N1 | 183 | 1.961 (1.421–2.704) | < 0.001 | 1.908 (1.300-2.799) | < 0.001 | |
N2 | 224 | 2.285 (1.672–3.123) | < 0.001 | 2.523 (1.743–3.653) | < 0.001 | |
Nx | 3 | |||||
Period of surgery: | 44 | |||||
2019–2021 | 198 | ref. | ref. | |||
2016–2018 | 221 | 0.881 (0.698–1.112) | 0.287 | 0.906 (0.678–1.210) | 0.504 | |
2013–2015 | 100 | 0.726 (0.542–0.972) | 0.031 | 0.680 (0.478–0.969) | 0.033 | |
≤ 2012 | 21 | 0.515 (0.262–1.112) | 0.055 | 0.282 (0.111–0.714) | 0.008 |